This is in contrast to previous observations in cancers, such as non-small-cell lung cancer, in which both elevated levels of eIF4E and inactivation of the 4E-BP1 repressor protein are the primary mechanisms for activating the eIF4F complex (Jacobson et al, 2006). The gene discussed is EIF4EBP1; the disease is non-small cell lung carcinoma.